<DOC>
	<DOCNO>NCT00907218</DOCNO>
	<brief_summary>The purpose research study learn efficacy medication call varenicline ( Chantix ) treat ADHD adult reduce cigarette smoking adult ADHD . The investigator hypothesize ADHD symptomatology adult ADHD improve varenicline treatment . The investigator also hypothesize varenicline treatment result significant reduction cigarette smoking . Another objective study fully evaluate response tolerability varenicline group cigarette smoking adult ADHD .</brief_summary>
	<brief_title>Chantix Adult Smokers With Attention Deficit Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>Male female outpatient 1860 year age ; A cigarette smoke history least 3 month , currently smoke ; An interest quit smoke willingness comply study procedure medication instruction ; A current DSMIVTR diagnosis ADHD confirm clinical psychiatric evaluation and/or ADHD module structure diagnostic interview , complete study clinician . For female childbearing potential : pregnancy test screen visit negative subject plan become pregnant study . Pregnancy breastfeeding ; Clinically significant and/or unstable medical condition include renal , hepatic , neurological , base upon medical history vital sign ; Ongoing treatment medication may affect ( alter blood level ) subject stop smoking study , include insulin , theophylline , blood thinner , determine clinician ; Clinically significant cardiovascular history , include myocardial infarction , untreated hypertension , atrial fibrillation , arrhythmia ; Current untreated psychiatric comorbidity investigator judge great mild severity , include Major Depressive Disorder ; Current psychiatric comorbidity , include suicidality , homicidality , psychosis , determine clinician clinically significant and/or unstable Lifetime history DSMIV Bipolar I disorder , Schizophrenia , suicide attempt determine clinical evaluation diagnostic interview ; Currently ( within 3 month ) meet DSMIV criterion abuse dependence psychoactive substance nicotine ; Current treatment mood stabilizer , antipsychotic , nicotine replacement therapy , varenicline ; Mental retardation ( IQ &lt; 75 ) ; History intolerance allergy varenicline . Clinically significant abnormal screen value include : Consistent reading hypertension ( &gt; 140/90 ) screening period ( include screen baseline visit ) , define two reading ( average three measurement ) single visit systolic blood pressure , SBP &gt; 140 and/or diastolic blood pressure , DBP , &gt; 90 , confirm manual reading . Subjects isolated incidence ( triplicate average BP ) SBP &gt; 140 and/or DBP &gt; 90 baseline/week 0 visit , confirm manual reading , determine clinically significant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>ADHD medication</keyword>
	<keyword>Chantix</keyword>
	<keyword>varenicline</keyword>
	<keyword>smoking</keyword>
	<keyword>smoke cessation</keyword>
	<keyword>quit smoking</keyword>
</DOC>